CERT
Certara, Inc.
$6.31
+0.00%
2026-05-08
About Certara, Inc.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Key Fundamentals
P/E Ratio
89.80
Forward P/E
12.65
EPS (TTM)
$-0.01
ROE
-0.1%
Revenue Growth (YoY)
3.3%
Profit Margin
-0.4%
Debt/Equity
28.96
Price/Book
0.93
Beta
1.53
Market Cap
$952.1M
Avg Volume (10D)
2.4M
Recent Breakout Signals
No recent breakout signals detected for CERT.
Recent Price Range (60 Days)
60D High
$7.52
60D Low
$5.19
Avg Volume
3.5M
Latest Close
$6.31
Get breakout alerts for CERT
Sign up for Breakout Scanner to receive daily notifications when CERT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Certara, Inc. (CERT) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CERT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CERT operates in the Healthcare sector within the Health Information Services industry. Data is provided for informational purposes only and does not constitute financial advice.